"Treating our first subject in this study reflects the recent advances in the field of gene therapy and is the culmination of years of collaborative effort between the team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and our colleagues at Massachusetts General Hospital, INSERM in Paris, and bluebird bio" "Treating our first ... (more)
http://www.businesswire.com/news/topix/20131028005758/en
http://www.businesswire.com/news/topix/20131028005758/en
No comments:
Post a Comment